Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator. This is to expedite the optimisation of a new class of COVID-19 therapeutics created using its artificial intelligence (AI) drug design platform. 
Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it could - and should - mean for health tech.
Matt Hancock's downfall as health and social care secretary was swift. On Friday, barely 12-hours after he had delivered the keynote speech to the NHS Confederation’s annual conference, The Sun newspaper published a CCTV grab of him enjoying a "steamy clinch" with an aide.
CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from Chicago, USA-based R1 RCM.
With the acquisition of Optima Corporation, CSAM Health Group will bring market-leading Optima products, impressive customer base and skilled teams in Auckland, New Zealand, Chicago, US, and Reading, UK, into the CSAM family.
Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines. 
The U.S. Food and Drug Administration authorized marketing of a device to help diagnose autism spectrum disorder (ASD). The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential symptoms of the disorder. 
Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be able to order lab based COVID-19 tests and see the results.